Press Releases April 14, 2026 08:00 PM

Carriage Services Declares Quarterly Cash Dividend

Carriage Services Declares Quarterly Dividend to Reward Shareholders

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
CSV

Carriage Services, Inc., a US-based provider of funeral and cemetery services, announced a quarterly cash dividend of 11.25 cents per share, payable June 1, 2026, to shareholders of record May 4, 2026. The company operates 155 funeral homes and 28 cemeteries across multiple states, emphasizing innovation and elevated service.

Carriage Services Declares Quarterly Cash Dividend
CSV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Declaration of quarterly cash dividend of $0.1125 per share.
  • Dividend payable on June 1, 2026, to shareholders of record as of May 4, 2026.
  • Carriage Services operates 155 funeral homes in 24 states and 28 cemeteries in 9 states, showcasing strong footprint in the death care services sector.

HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced that its Board of Directors on April 15, 2026, declared a quarterly dividend of 11.25¢ per share payable on June 1, 2026, to common share record holders as of May 4, 2026. 

Carriage Services is a leading provider of funeral and cemetery services and merchandise in the United States. Carriage operates 155 funeral homes in 24 states and 28 cemeteries in 9 states as of March 31, 2026. It is dedicated to delivering premier experiences through innovation, partnership, and elevated service.

For more information, please email [email protected].


Risks

  • Dependence on economic conditions that can affect consumer spending on funeral and cemetery services.
  • Potential regulatory changes in the funeral and cemetery services industry.
  • Market competition and operational risks related to managing multiple locations across various states.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026